DESKi Closes $6M Seed Round to Bring AI-Powered Heart Scans to Market

Funding follows FDA clearance and landmark trial validating novice-led cardiac imaging

BORDEAUX, France–(BUSINESS WIRE)–June 18, 2025–

DESKi, a healthtech company developing AI-powered diagnostic tools in collaboration with clinicians and researchers, today announced the close of a $6 million seed round to support the U.S. and global market launch of its FDA-approved cardiac imaging software, HeartFocus.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250618211336/en/

DESKi closes $6M seed round thanks to Racine², an impact-focused fund managed by Serena and Makesense, with participation from BNP Paribas Développement, Épopée Gestion, Good Only Ventures, Better Angle, and NACO, the Nouvelle-Aquitaine regional fund advised by M Capital.